Biogen completed the acquisition of RayThera Inc.

Alterity Therapeutics will present at the 46th An

Tarsus Pharmaceuticals has entered a definitive a

Former FDA officer Abha Kundi explains what the

FDA designation signals growing interest in ther

New collaboration between Longevity AI and Meir

Competition prioritizes human evidence and clini

Restore Hyper Wellness has launched a nationwide

The Global Coalition on Aging and the Malaysian H

Cirrus Therapeutics announced a research collabor

Insilico Medicine nominated ISM9077 as a preclini

A single AAV injection protected five organs in

A new clinical-grade DNA test could mark the mom

$115m financing and the launch of global Phase 2

A new evolutionary framework suggests research i

CND Life Sciences completed a growth financing ro

Cortechs.

FibroBiologics announced that the European Patent

XellSmart announced that XS411, its allogeneic of

Clearway Pain Solutions is offering the Intracept

Integrated longevity platform aims to make conti

Ahead of Longevity Investors Conference, Steve H

Early success in national $7 million competition

Altimmune began patient enrollment in the PERFORM

4Moving Biotech has completed enrollment in INFLA

Niagen Bioscience has selected Evotec as the cont

Haut.

Vivoo’s CEO explains how continuous biomarker

Interim trial data suggest a safer way to target

Lancet paper suggests zabopegdutide may act dire

Generation Lab is sharpening its position in long

Genflow Biosciences Plc reported progress across

Genflow has secured fast-track US examination for

Human Longevity, Inc.

Exclusive US rights to ALA-002 give the longevit

A bootstrapped company is betting that precision

AI partnership aims to bring earlier detection a

Wearables, DNA tests and biomarkers promise heal

EHE Health has partnered with Prenuvo to offer se

EHE Health has partnered with Prenuvo to offer se

Insilico Medicine launched the Drug Discovery and

Aspen Neuroscience announced that sasineprocel (A

New research suggests exceptional memory may dep

New analysis suggests patented NR may influence

With first patient cohort completed, Serina is a

NADclinic and GCLS partner to strengthen clinici

Antag has dosed the first patient in a Phase 2a t

VoxNeuro has received U.S.

Researchers at Imperial College London are integr

Nicola Marino looks at a new paper proposing an